\n
About CureCurrent

See where medicine is going.

CureCurrent organizes public disease, drug and clinical-trial data into a connected research view designed to make changes, relationships and geographic activity easier to understand.

What CureCurrent does

CureCurrent connects disease concepts, drug concepts, clinical trials, sponsors, research geography and time. The goal is not simply to list records, but to make it easier to see what is being studied, where activity is occurring, which organizations are active and how research changes over time.

Primary data sources

  • ClinicalTrials.gov for clinical-trial registry records and study status.
  • MONDO for normalized disease and disorder terminology.
  • RxNorm for normalized drug terminology.

Additional public sources may be added when they improve provenance, coverage or interpretation. Source identity is kept separate from CureCurrent's derived views.

How we treat evidence

CureCurrent distinguishes canonical entities, source assertions and derived analytics. A relationship is not treated as clinically verified merely because two terms appear together in a source record. Ambiguous mappings are kept separate until there is sufficient evidence to resolve them.

What CureCurrent is not

CureCurrent is not a healthcare provider and does not provide medical advice, diagnosis, treatment recommendations or prescribing guidance. Clinical-trial and drug information can change; users should consult the underlying source and qualified professionals when making healthcare decisions.

Where the product is going

CureCurrent includes browsable disease, drug, trial, raw condition, raw intervention, sponsor and location pages, with a searchable Research Index. Location pages connect mapped cities to real ClinicalTrials.gov trial-site relationships with paginated trial lists and per-trial site-observation counts. Disease and drug pages can also carry clearly labeled Wikipedia/Wikidata background when an exact external-identifier match is available; that context remains separate from MONDO, RxNorm and ClinicalTrials.gov evidence. Planned work includes deeper geography coverage, longitudinal change intelligence, alerts, comparisons and professional data/API products.